lobbying_activities: 2189209

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2189209	7902221c-3005-4343-b5b7-1464f5398b6e	Q3	THE D MAJOR GROUP	401103162	ALLERGAN INC (FORMERLY ACTAVIS INC )	2018	third_quarter	PHA	Monitor issues concerning bioequivalence standards for pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE,White House Office	50000		0	0	2018-10-17T17:16:37.977000-04:00